Sat.Sep 10, 2022 - Fri.Sep 16, 2022

article thumbnail

Is Apple that naive when it comes to compliance?

World of DTC Marketing

Apple’s Health app gets new capabilities with iOS 16. The Health app adds Medications, allowing users to conveniently build and manage a medications list, create schedules and reminders, and track their medications, vitamins, or supplements. Will it matter? The health app will also tell users about potential interactions between medications, and it’s possible to connect with healthcare providers to see a list of past medications, get future updates, or add items to your schedule.

Medical 166
article thumbnail

Novo Nordisk partners with Microsoft for AI-driven drug discovery

Pharmaceutical Technology

Novo Nordisk has signed a new strategic partnership with Microsoft to expedite the discovery and development of drugs leveraging big data and artificial intelligence (AI). Under the deal, Microsoft's computational services, Cloud and artificial intelligence (AI) will be merged with the drug discovery, development and data science expertise of Novo Nordisk.

Training 139
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Manufacturing Edge on Path to Market

PharmExec

FDA backs the benefits of adopting continuous manufacturing, a strategy which has accelerated approval and launch timelines, and its Emerging Technology Program could be a helpful tool.

article thumbnail

The future of AI drug discovery & development in immunology and GPCR research

pharmaphorum

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. A mere six months ago Verily launched the study with Sosei Heptares – a global leader in GPCR structure-based drug design – with an aim to “prioritise protein targets for therapeutic targeting in immune-mediated disease”.

Leads 128
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

What’s wrong with healthcare and how do we fix it?

MedCity News

The problem with the US healthcare system is one of misaligned incentives. Prescribers are paid to evaluate patients and to administer care. All prescribers want the best outcomes for their patients, but the system does not incentivize choosing the best medications to promote those outcomes. Instead it is incentivized to pay for only the medications prescribed.

article thumbnail

Motion Sensors to Detect Age-Related Disease

Medgadget

Researchers at the University of Bern in Switzerland have developed a motion tracking system that is intended to assist in detecting age-related disease in elderly people. The system could be installed in someone’s home or in assisted-living facilities, and consists of a series of motion sensors that can monitor for signs of unusual movement. The system can inform caregivers if an emergency arises, such as a fall, which can be detected when someone does not return to their bed at night or is sta

Medicine 115

More Trending

article thumbnail

Gilead’s Veklury receives WHO recommendation to treat severe Covid-19

Pharmaceutical Technology

Gilead Sciences has received expanded recommendation under the World Health Organization’s (WHO) Therapeutics and COVID-19: living guideline for the use of Veklury (remdesivir) to treat severe Covid-19 patients. The guideline update comes after the treatment received recommendation from the health agency for treating non-severe Covid-19 in patients at increased risk of hospitalisation.

article thumbnail

Digital health transformation requires holistic not episodic care

MedCity News

By following the patient at each stage of its disease progression, from diagnosis to disease management, and integrating a variety of technologies, digital health provides deeper insights and help for care management.

article thumbnail

3D Printed Tablets for Controlled Drug Release

Medgadget

Researchers at the University of the Basque Country have developed a technique that allows them to 3D print pharmaceutical tablets using different types of starch. By modifying the types of starch used and the shape of the tablets, the team can fine-tune drug release to be either rapid or slow. This includes full release of the encapsulated drug in as little as ten minutes to as long as six hours, providing significant scope to address a wide variety of therapeutic situations.

Medicine 108
article thumbnail

CCC Launches OA Agreement Intelligence

Copyright Clearance Center

Sept. 13, 2022 – Danvers, Mass. – CCC , a leading provider of Open Access (OA) workflow solutions, has launched OA Agreement Intelligence , the only agreement modeling solution that enables publishers to prepare, build, and analyze their OA data so that they can create and communicate sustainable and transparent agreements with their partners. The solution combines sophisticated data preprocessing with easy-to-use analysis and export capabilities.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database.

Sales 108
article thumbnail

Delivering Improved Disease Awareness Through More Strategic Partnerships

PM360

Can an art installation teach you about a disease? How about a song? Or a dance? Can more than 20 pharma companies unite around messaging for biomarker testing even though everyone seems to call it something different? And can the mistrust and skepticism minority communities have toward the healthcare system be overcome to spread crucial disease awareness?

Education 105
article thumbnail

AN APPROACH TO THE HAIR FALL & HAIR GROWTH MANAGEMENT

Pharmatutor

AN APPROACH TO THE HAIR FALL & HAIR GROWTH MANAGEMENT. About Authors Avdesh Thassu. MPharm (Nat. Chem.); MBA(Mkt.). Associate Vice President. Global Regulatory Affairs, Emami Limited, 7044455199. athassu@hotmail.com. Chandra Mohan Nandi. MSc. (Organic Chem.). Deputy Manager, Global Regulatory Affairs, Emami Limited, 9051706947 chandramohannandi@yahoo.in. admin.

article thumbnail

FDA starts review of first drug for alpha-mannosidosis, from Chiesi

pharmaphorum

The FDA has started a priority review of Chiesi ‘s velmanase alfa, an enzyme replacement therapy for lysosomal storage disease (LSD) alpha-mannosidosis, with a decision expected in the first half of 2023. The vanishingly rare, progressive, and debilitating disease is caused by a deficiency in the enzyme alpha-mannosidase, leading to a build-up of complex sugars that damage the central nervous system and organs of the body.

FDA 103
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Medsembly launches digital mentorship platform for students entering the healthcare field

MedCity News

Medsembly, an Atlanta-based startup that connects students who want to get into healthcare with working professionals in their prospective careers, launched an interactive digital mentoring platform. The platform allows students to connect with healthcare professionals who can give them advice on things like how to get into medical school, how to land a residency and what day-to-day activities they can expect in their prospective career.

article thumbnail

Red Jacket: Fabio Gratton

PharmaVoice

The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.

98
article thumbnail

4 Steps to Make Hybrid Work for Your Workplace

PM360

The virtual workplace was a two-year experiment. Now, the next one begins: hybrid work. Partly in the office, partly from home—it seems to be the way forward. So how should organizational leaders support the hybrid work model to make the most of it? To explore this question, we launched a longitudinal study of the U.S. workforce. Our results suggested that when employees felt their leaders actively supported the virtual work environment, they were more engaged and innovative, experienced less bu

Pharma 98
article thumbnail

The use of genomic profiling testing to improve oncology care

pharmaphorum

Dr Prasanth Reddy, head of oncology at LabCorp, tells us how the company works with cancer care teams, biopharma partners, and patients as an integral part of the patient journey from testing to treatment. The oncology sector has transformed over the past several decades thanks to the rise of technological advances. Through partnerships and internal innovation, LabCorp is utilising these advances in order to improve healthcare stakeholders’ experiences for better patient results.

Patients 103
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Yuvo Health launches initiative to make value-based care easier for FQHCs

MedCity News

Yuvo Health launched a new initiative to provide FQHCs with administrative and managed contract services to help them adopt value-based care. The New York startup partnered with the Primary Care Development Corporation to co-develop training programs and support resources to ensure FQHCs are positioned for success in these care models.

Training 102
article thumbnail

Red Jacket: Jim Lang

PharmaVoice

The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.

98
article thumbnail

Embedding the Patient Point of View in Everything You Do

PM360

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric? If its patient-centric strategies were actually working?

article thumbnail

ESMO: TIL therapy improves on Yervoy in melanoma trial

pharmaphorum

A personalised cell therapy based on tumour-infiltrating lymphocyte (TIL) cells has been shown to be more effective at improving progression-free survival than Bristol-Myers Squibb’s immunotherapy Yervoy in patients with advanced melanoma. It is the first time that a cell therapy for solid tumours has been tested in a phase 3 trial, and the first time that the approach has been directly compared with standard second-line immunotherapy in melanoma.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

CarePoint sues RWJBarnabas over alleged care monopolization scheme

MedCity News

CarePoint Health, a three-hospital health system in New Jersey, recently filed a lawsuit against RWJBarnabas Health, the largest acute care provider in the state. The complaint alleged that RWJBarnabas conspired with real estate investors, New Jersey’s largest payer and government officials to eliminate competition and monopolize acute care services in the state.

article thumbnail

Takeda to invest €300 million in plasma-derived therapy production

European Pharmaceutical Review

Investing close to €300 million, Takeda plans to construct a new state-of-the-art production facility for plasma-derived therapies and a net-zero carbon emissions warehouse in Lessines, Belgium – the largest investment Takeda has ever made in the country. The investment is part of the company’s global effort to implement the most innovative technologies and most sustainable processes at its manufacturing sites.

article thumbnail

Two Key Questions About Patient Experience in 2022

PM360

PM360 asked industry experts what it takes to be a patient-first organization and how companies can better ensure they are delivering experiences that meet patients’ expectations. Specifically, we asked them: What is required today for life sciences companies to truly practice a patient-first approach? In what areas are companies still failing to live up to this promise?

article thumbnail

Novartis probed by Swiss authorities over ‘unlawful’ patent use

pharmaphorum

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.” The Swiss Competition Commission (COMCO) arrived unexpectedly at Novartis at dawn on Tuesday morning, to gather information on an unidentified dermatology drug, as part of a wider investigation into the drugmaker by the European Commission.

article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

Woman of the Week: Agilent Technologies’ Dr. Katharine Knobil

PharmaVoice

As the first chief medical officer of the diagnostic testing company, Dr. Katharine Knobil is focused on moving the science forward beyond precision oncology to liquid biopsy.

Medical 98
article thumbnail

Is localisation the answer for pharmaceutical supply chain resilience?

European Pharmaceutical Review

We have reported several times on supply chain resilience since the start of the COVID-19 pandemic, 1-3 as the world experienced unprecedented lockdowns and supply disruptions, with interruptions to manufacturing as well as both air transportation and shipping routes. Since the developed regions of the world started to get COVID-19 under control, focus on this matter has only grown – particularly in the pharmaceutical sector, which played a critical role in curbing the devastation caused by the

article thumbnail

Outsourcing your Parenteral Manufacturing - Choosing the optimal CDMO

PharmaTech

You have your drug substance and need a parenteral formulation to administer it. This podcast will focus on the key factors to consider when choosing the ideal parenteral manufacturing CDMO partner.

article thumbnail

Potrero Medical Receives FDA Breakthrough Device Designation for Accuryn AKI Predict Algorithm

Legacy MEDSearch

Potrero Medical announced that the FDA granted Breakthrough Device Designation for their AKI Predict machine learning algorithm, for the advanced prediction of acute kidney injury (AKI) associated with intra-abdominal hypertension (IAH) in cardiac post-surgical intensive care patients. Joe Urban, Potrero CEO stated “We celebrate the breakthrough designation, and we are excited about what this will mean for patients, providers and health systems in the future.” Urban further commented

Medical 98
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time